Suvarna Swasthya Research Centre Private Limited
Vision:
Salutogenesis: Formation of Health
Mission:
Creating Enduring Partnerships in a Sense of Coherence::
Comprehension: A clear understanding of the Health Condition
Capacity: An ability to cope with the Health Condition
Capability: An ability to pursue a purposeful life with Autonomy and Dignity
SSRC is a mission directed enterprise grounded in "One Health" and "One Planet" and a proud member of the HAPPEN Consortium dedicated to participatory action strategies in advancing Health.
https://www.who.int/news-room/questions-and-answers/item/one-healthhttps://www.oneplanetnetwork.org/
Call for appointment: 91-7893003300
Clinical Services: Compassionate Continuum of Care for Recovery Recuperation Rejuvenation
Our physicians are anchored in the best attributes of holistic compassionate Indian tradition of providing accurate and comprehensive diagnostic and therapeutic intervention that encompasses cost effective modern personalized precision medicine that focuses on the entire continuum of inborn personal attributes; the environment; diet; lifestyle to allow rapid recovery; recuperation and rejuvenation. Our goal is to ensure ability to meet the demands of life.
Clinicians:
Professor Vijay V. Yeldandi, M.D., FACP, FCCP, FIDSA is the chief of infectious diseases, Chairman Hospital Infection Control Committee and director of the Inflammatory Disorders Clinic at Continental Hospitals, Hyderabad. Dr Yeldandi has a special interest in infections complicating autoimmune disorders; transplantation as well as patients with HIV infection and other infections related to travel. He has expertise in managing diseases of the immune system and inflammatory disorders, with over three decades of experience in both USA and India. He embraces state-of-the-art technology with compassion to empower individuals to take ownership of their own health and have a purposeful life with autonomy and dignity.
A clinician and educator, he is an alum of the prestigious Gandhi Medical College, Hyderabad, and trained as a superspecialist (fellowship) in infectious diseases at Loyola University of Chicago. A resolute advocate for patient safety and infection prevention; he has received numerous awards for excellence in teaching and leadership for public health in India. He is a member of the Community of Practice for “Implementing Public Policy” Harvard Kennedy School of Government. He serves as an advisor to the Ministry of Health (Technical Resource Group of NACO) and for Infection Prevention and Control (Government of Telangana and Andhra Pradesh)
Dr. Undurti N Das, MD, DSc, FAMS, FRSC is a physician/scientist, who has performed translational research in the area of cancer, diabetes mellitus, lupus, coronary heart disease, atherosclerosis, sepsis and radiation protection. His laboratory studies led to a deeper understanding of the role of polyunsaturated fatty acids and their metabolism in several diseases that have the potential to be translated into newer therapeutic strategies. Dr Das has over 500 scientific publications and has authored several books.
His Current appointments are:
Consultant Physician & Diabetologist
Clinical Immunologist & Rheumatologist
CMO, Asha Nutrition Sciences, Inc., CA, USA
Founding Editor Lipids in Health and Disease by BMC
www.lipidworld.com
Editor-in-Chief: Current Pathobiology Reports
by Springer-Nature
Review Editor: Nutrition by Elsevier
Academic Editor: Medicine by Kluwer
and
CEO/CSO of UND Life Sciences, 2221 NW 5th St, Battle Ground, WA 98604, USA and Chief Medical Officer and Chairman of the Scientific Advisory Board, ASHA Nutrition, CA, USA.
- Editor-in-Chief, Lipids in Health and Disease, BioMed Central, UK.
- Editor-in-Chief, Current nutrition and Food Science, Bentham Publishers.
- Review Editor, Nutrition, Elsevier, USA.
- Academic Editor, Medicine, USA
Honors
1989: Shakuntala Amir Chand Prize of Indian Council of Medical Research
1992: Shanti Swaroop Bhatnagar prize of Council of Scientific and Industrial Research, India for work on GLA and glioma
1992: Dr. Coelho Memorial Award by Association of Physicians of India in Experimental Medicine
2011:Innocentive award for developing a urinary marker for lupus
Dr. Shikha Dhawan, PhD, PGDM - Director-Public Health, Suvarna Swasthya Research Centre
Dr. Shikha has amassed 19+ years of experience in health research and public health with a great acumen in high-quality patient-centric healthcare solutions: preventing, intercepting and curing diseases. She has a post-doctorate in Biomedical Research, USA with a PhD in Microbiology, India and PGDM in Biotechnology Business Management, India. As Director Programs, SHARE INDIA, Dr. Shikha works with National AIDS Control Organization, Government of India. As Director-Public Health, Suvarna Swasthya Research Centre, Dr. Shikha works in bringing new diagnostics to the market utilizing community centric HAPPEN model. In the past, she has served as Executive Director, Partasia Biopharm (2016-2021)& National Consultant-TB laboratories, National Tuberculosis Elimination Program (NTEP) (2012-2016). As Manager-Malaria Vaccines (2008-2012) and Research Scientist (2004-2008) at International Centre for Genetic Engineering and Biotechnology (ICGEB, New Delhi), she was part of the team engaged in discovery of novel malaria vaccine candidates, preclinical and clinical trials.
Inspired living with conscious pursuit and passion to change lives for the lesser privileged makes her laser focused on women’s empowerment, women’s self-reliance and environment sustainability. Her career path is embellished with working for women self-help groups, farmer producer organizations, mentoring startups and bringing new products and diagnostics to the market. Working meaningfully with governments, academia, development sector, non-profits, and private sector, she is trained in Leadership and Management in Health, Corporate Social Responsibility, Public Health Communication Campaigns and Medico Legal aspects in healthcare. She has travelled extensively within India even to remotest districts and villages; touched lives and made meaningful societal impact. She has presented research policy and public health work at multiple international forums in USA, Europe, Asia and Africa.
Dr. Radha Reddy Chada is dedicated to creating personalized nutrition plans to enhance the health and well being of our patrons. Dr. Radha R Chada, Lead Clinical Dietitian having more than 25 years of experience in nutrition research, teaching, training.
Radha Chada is a Registered Dietician with a PhD in Clinical Nutrition and Dietetics. She specializes and has keen interest in Critical Care Nutrition and Metabolic Disorders.
Dr. Pamela Narayan MSc, BPTh/BPT is a Physiotherapist and Neuro Physiotherapist and has an experience of 31 years in these fields. Dr. Pamela Narayan completed MSc. - Physiotherapy from University of London, United Kingdom in 1998 and BPTh/BPT from Christian Medical College, Vellore, T.N in 1989. She is a member of Indian Society of Physiotherapy,Chartered Society of Physiotherapy, London,World Federation of Hemophilia,World Federation for Neuro Rehabilitation,Indian Federation of NeuroRehabilitation,InternationalUrogynecologicalAssociation,Indian Society of Perinatology and Reproductive Biology and BBTA Certified Physiotherapy. Some of the services provided by the doctor are: Neuro Developmental Therapy, Orthopaedic Physiotherapy, Functional Tissue Release (LTF),Elastic bandage and Clinical Physiotherapy etc..
SSRC Reference and Research Laboratory Services:
State of the art automated equipment for high precision reliable diagnostics in infectious diseases:
Automated culture instrument that allows continuous sampling in real time for rapid identification of growth of bacteria (including Mycobacterium tuberculosis) and many fungi.
A high precision automated instrument for identification as well as antimicrobial susceptibility testing
VITEK MS is an automated mass spectrometrymicrobial identification system that uses Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) technology.
VITEK MS contains a comprehensive FDA 510(k) cleared database for bacteria and fungi, including mycobacteria, Nocardia and molds—now including Brucella, Candida auris and Elizabethkingiaanophelis.
- Robust & accurate identifications with Advanced Spectra Classifier
- Seamless integration of ID/AST results for optimized workflow
- Complete traceability & flexibility
FEATURES
Fast and Actionable Identification for Better Patient Outcomes
VITEK MS helps laboratories deliver actionable results to clinicians to support informed treatment decisions.
Accurate, Robust Results
- bioMérieux’s proprietary Advanced Spectra Classifier offers robust and accurate results needed for optimal patient-care decisions.
- The VITEK MS system reads each spectrum as a series of peaks that are detected and sorted by mass and intensity.
- With the use of the Advanced Spectra Classifier, better discrimination is provided as every peak is considered in the calculation of the identification result.
- There are no spectra comparisons, and the reference spectra are not embedded in the commercial software.
The VITEK MS contains a population built database, accounting for diversity among strains within the same species, leading to robust and accurate performance without the need to modify scores.
The database is built to allow for better discrimination between species. This is accomplished by including spectra for each species generated from:
- An average of 12 strains per species and an average of 35 spectra per species
- Geographical diversity of isolates
- Isolates of different sample origins (e.g., blood, tissue, etc.)
- Isolates sub-cultured on different media
- Isolates with different incubation times
VITEK MS Knowledge Base V3.2
A comprehensive database update for mycobacteria, Nocardia, and molds—now including Brucella, Candida auris and Elizabethkingia anophelis.
- The VITEK MS database is continually expanding to identify new emerging pathogens and clinically relevant species.
- The VITEK MS V3.2 FDA 510(k) cleared database for bacteria and fungi contains mycobacteria, Nocardia and molds.
- This enhanced database includes Mycobacteria tuberculosis (TB), non-tuberculous mycobacteria (NTM), dermatophytes and dimorphic fungi, including the most prevalent species relevant to patient infections.
- The ability to quickly identify these difficult organisms on a mass spectrometry system allows microbiologists to provide clinicians with actionable results to aid in quicker treatment for diseases such as tuberculosis, osteomyelitis caused by NTM, and serious fungal infections.
- VITEK MS’s excellent performance in identifying mycobacteria, Nocardia and molds, allows results to be rapidly released to physicians for better patient care.
- This helps hospitals save both money (molecular probes; sequencing; send-outs) and time (in-house testing; faster identification of these difficult organisms).
- The VITEK MS V3.2 database now includes Brucella, Candida auris, and Elizabethkingiaanophelis.
- Brucella species are difficult to recognize and hazardous to laboratory personnel. Quick identification reduces exposure to laboratory personnel and enhances safety. Both Candida auris and Elizabethkingiaanophelis are new emerging pathogens of clinical significance.
KNOWLEDGE BASE
bioMérieux's proprietary algorithm –Advanced Spectra Classifier (ASC) - uses a weighted bin matrix to build the Knowledge Base reference strain database. The knowledge base includes data representing 1,316 taxa.
- 207 molds and yeast
- 16 Nocardia
- 39 Mycobacteria
- There are on average 40 reference spectra per species covering strain variation, media types, and growth conditions.
- To create the bin matrix, reference spectra for all species are divided in 1,300 pre-defined bins and bin weights are calculated based on the presence or absence of a peak in a bin and whether this is specific for a certain species compared to all other species in the database.
- Once a spectrum is generated from the test sample, the raw data are processed to eliminate baseline values and noise so that significant peaks can be detected.
- The spectra is then divided in the 1,300 bins and the peak patterns are compared with those for all species in the knowledge base.
- By computing the sum of the bin weights against all species in the database a relative score is generated and converted to a probability percentage and confidence value.
- This binning algorithm enables unambiguous identification of an organism with a confidence level greater than 99%.
The approach of analyzing 1,300 data points of each spectrum rather than comparing spectral patterns is very robust for high confidence identification and differentiation of species that have a very closely related protein content and spectral profile. The process enables fast analysis time and improved accuracy over existing methods.
DATABASE ROBUSTNESS
The VITEK MS is a clinically focused database that contains multiple reference strains from:
- Different regions of the world
- Different specimens
- Different media types and growth conditions to create multiple spectra per species
BENEFITS
MEDICAL VALUE
Delivering outstanding, cost-effective care to patients is highly dependent on a clinician’s ability to access the right information at the right time.VITEK MS supports antimicrobial stewardship programs with microbial identification in minutes and by providing benefits to both laboratory personnel and clinicians.
Results in minutes
- Provides fast and actionable results to initiate optimal therapy
- Broad coverage of clinically significant organisms
Highly accurate results
- Comprehensive database of clinically significant organisms
Rapid results help improve positive patient outcomes
- Reduction in time to optimal antibiotic therapy1
- Helps reduce length of stay, total hospital costs and mortality
LABORATORY AND ANTIMICROBIAL STEWARDSHIP BENEFITS
Benefits for labs
- Ability to identify organisms previously difficult to ID with traditional methodology
- Up to 51.7% decrease in identification cost per isolate2
- Comprehensive & clinically relevant database
- Expanded database of 1,316 organisms including Mycobacteria, Nocardia and Molds
- Now including Brucella species, Candida auris, and Elizabethkingiaanophelis
- User-friendly software
- Fully integrated with VITEK® 2 susceptibility testing
Benefits for ASP & clinicians
- Helps reduce time to appropriate therapy
- Helps reduce hospital length of stay5
- High confidence in organism result – highly accurate identifications
SSRC Commitment to the campaign to address Anti-Microbial Resistance:
Antibiogram of pathogens are updated in WHO NET on daily basis which is essential for Global Surveillance of Anti-Microbial Resistance.
SSRC Commitment to TB Mukht Bharat:
The data of individuals who are Positive for Acid Fast Bacilli are uploaded in NIKSHAY Portal.
As a part of advancement in diagnostics and research, SSRC is now equipped with Anti Tubercular Drug Sensitivity Testing through Sensititre method. This advancement gives an edge to clinicians for precise tailored treatment of Mycobacterial infections and prevention of drug resistance.
SSRC Commitment to Education Training and Research:
SSRC also promotes and provides academic learning opportunities for Medical Postgraduates and PhD's in Clinical Microbiology including guidance and mentorship for project work using advanced technology. SSRC provides laboratory technical certified training programs for Laboratory technologists.
SSRC Commitment to Infection Prevention and Control:
SSRC provides comprehensive solutions for Infection Prevention and Control as a program for hospitals and also facilitates training and capacity building for IPC professionals and other allied health professionals.
SSRC Commitment to “One Health” :
SSRC provides diagnostic laboratory support to Veterinary, Agriculture and Food processing industries.
SSRC Commitment to “One Planet” :
Power for the laboratory is supplied by Solar Power:
Our Laboratory Professionals:
Dr. B. G. Viswanath, MD is a Consultant Microbiologist, Medical Director of Suvarna Swasthya Research Centre Private Limited and a Certified Professional in Hospital Infection Prevention and Control. He is an alumna of Gandhi Medical College and obtained his MBBS degree in the year 2008 and MD degree in the year 2014 from the same prestigious institute. He is skilled in applying clinical aspects of Microbiology in Laboratory Medicine, Hospital infection prevention and control programme and Antimicrobial Stewardship programme.
He is a member of expert reviewer community in National Institute for Health Research, United Kingdom.
He is Trained in Laboratory Quality Management System and Internal Audit as per ISO 15189 : 2012. Dr. Viswanath has published articles and reviews manuscripts from various international journals. He worked on Anaerobic Bacteriology and adding to his credentials, he first reported from India a “Multidrug-resistant Bacteroides fragilis isolated from a case of pyopneumothorax” and published in British Journal of Medicine and Medical Research.
He published original research article “Emergence of antimicrobial resistance among anaerobic bacteria” in American Journal of Infectious Diseases and Microbiology.
He collaborated with Global Health Research, aided by National Institute for Health Research, UK. Global surveillance of Bacterial pathogens is carried out using whole genome sequencing in Central Research Laboratory, KIMS Hospital and Research Centre, Bangalore.
Dr. Viswanath has been invited as a guest speaker in CME programmes and conferences.
He received awards like B. Krishna Rao Memorial award and Dr. Satyanarayana Memorial award.
B. Vandana is a Senior Scientist and obtained her MSc in Biotechnology from Oxford College, Bangalore University. She worked on antihelminthic properties of Circuma longa, analysis of degree of contamination of borewell water in Bangalore Industrial area. She is currently working on Mass Spectrometry, Conventional and Automated Microbiology.
Mrs. Gayathri Karavadi MA, MBA Senior Manager and Headof Operations is certified in SAP (FICO) and Six Sigma. She has over 30 years of experience with various organizations: M/S. Coastal Oil & Gas, Karvy Consultants Ltd, Deccan Enterprises and Medwin Hospitals. She is passionate about ensuring the best possible health care and experience for everybody at SSRC.
Our Clients:
- MAA ENT Hospitals
- Apollo Hospitals
- Apollo Institute of Medical Sciences
- Care Hospitals
- Gandhi Medical College
- Osmania Medical College
- Basavatarakam Indo American Cancer Hospital
- Nizam’s Institute of Medical Sciences
- L V Prasad Eye Institute
- Yashoda Hospitals
- BBR Hospitals
- Onus Hospital
- KIMS Hospitals
- Kamineni Institute of Medical Sciences
- ESIC Medical College & Hospital
- Srikara Hospitals
We devote five percent of all of our gross revenues towards uncompensated social investments addressing health needs of individuals or communities.
Power is an Illusion; Authority is a Delusion; RESPONSIBILITY is REALITY
https://www.linkedin.com/groups/10412579
https://www.facebook.com/HAPPENforOneHealth
https://www.youtube.com/channel/UC5YM8FnS-O4JsjWZEPrqnCA